Copyright
©The Author(s) 2023.
World J Gastroenterol. Jun 14, 2023; 29(22): 3519-3533
Published online Jun 14, 2023. doi: 10.3748/wjg.v29.i22.3519
Published online Jun 14, 2023. doi: 10.3748/wjg.v29.i22.3519
Figure 4 Comparison of the rebleeding-free rate between the patients with endoscopic therapy+non-selective β-blockers and covered transjugular intrahepatic portosystemic shunts.
A: The total cohort; B: Patients on low-hepatic venous pressure gradient (HVPG) tier; C: Patients on high-HVPG tier; TIPS: Transjugular intrahepatic portosystemic shunt; NSBBs: Non-selective β-blockers.
- Citation: Wang XX, Yin XC, Gu LH, Guo HW, Cheng Y, Liu Y, Xiao JQ, Wang Y, Zhang W, Zou XP, Wang L, Zhang M, Zhu-Ge YZ, Zhang F. Pre-transjugular-intrahepatic-portosystemic-shunt measurement of hepatic venous pressure gradient and its clinical application: A comparison study. World J Gastroenterol 2023; 29(22): 3519-3533
- URL: https://www.wjgnet.com/1007-9327/full/v29/i22/3519.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i22.3519